Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Gyan

Showing results (91-100 of 174) with videos related to

Pageof 18
Sort By:
Annals of Hematology|October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphomaEmilie Fargier, Florence Ranchon, Laure Huot, et al.
Haematologica|August 3, 2019
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET ProjectClément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, et al.
Scientific Reports|June 13, 2022
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AMLEmmanuel Gyan, Arnaud Pigneux, Mathilde Hunault, et al.
British Journal of Haematology|April 23, 2014
Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemiaEdouard Cornet, Cécile Tomowiak, Aline Tanguy-Schmidt, et al.
Clinical Immunology (Orlando, Fla.)|August 10, 2023
Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individualsNoémie Ravalet, Hélène Guermouche, Pierre Hirsch, et al.
Medicine|October 9, 2015
A French National Survey on Clotting Disorders in MastocytosisAna B Carvalhosa, Achille Aouba, Gandhi Damaj, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Haematologica|February 9, 2012
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphomaChristoph Renner, Pier Luigi Zinzani, Rémy Gressin, et al.
British Journal of Haematology|May 23, 2013
High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS studyEmmanuel Gyan, Diane Damotte, Stéphane Courby, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2019
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyDaniel Jaimes-Albornoz, Lionel Mannone, Stéphanie Nguyen-Quoc, et al.
Pageof 18

Showing results (91-100 of 174) with videos related to

Sort By:
Pageof 18
Annals of Hematology|October 11, 2017
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphomaEmilie Fargier, Florence Ranchon, Laure Huot, et al.
Haematologica|August 3, 2019
Prognostic value of FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET ProjectClément Bailly, Thomas Carlier, Alina Berriolo-Riedinger, et al.
Scientific Reports|June 13, 2022
Adjunction of a fish oil emulsion to cytarabine and daunorubicin induction chemotherapy in high-risk AMLEmmanuel Gyan, Arnaud Pigneux, Mathilde Hunault, et al.
British Journal of Haematology|April 23, 2014
Long-term follow-up and second malignancies in 487 patients with hairy cell leukaemiaEdouard Cornet, Cécile Tomowiak, Aline Tanguy-Schmidt, et al.
Clinical Immunology (Orlando, Fla.)|August 10, 2023
Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individualsNoémie Ravalet, Hélène Guermouche, Pierre Hirsch, et al.
Medicine|October 9, 2015
A French National Survey on Clotting Disorders in MastocytosisAna B Carvalhosa, Achille Aouba, Gandhi Damaj, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Haematologica|February 9, 2012
A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphomaChristoph Renner, Pier Luigi Zinzani, Rémy Gressin, et al.
British Journal of Haematology|May 23, 2013
High response rate and acceptable toxicity of a combination of rituximab, vinorelbine, ifosfamide, mitoxantrone and prednisone for the treatment of diffuse large B-cell lymphoma in first relapse: results of the R-NIMP GOELAMS studyEmmanuel Gyan, Diane Damotte, Stéphane Courby, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2019
Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular TherapyDaniel Jaimes-Albornoz, Lionel Mannone, Stéphanie Nguyen-Quoc, et al.
Pageof 18